Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0001415889-24-019463

EVP, GLOBAL SALES sold 33,333 shares at an average $4.03 ($134,366)

  • EVP, GLOBAL SALES acquired 33,333 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ross Thomas M. EVP, GLOBAL SALES 2024-07-08 Option exercise 10b5-1 +19,802 $1.64 $32,495 44,802 D
Ross Thomas M. EVP, GLOBAL SALES 2024-07-08 Sale 10b5-1 −19,802 $4.03 $79,782 25,000 D
Ross Thomas M. EVP, GLOBAL SALES 2024-07-09 Option exercise 10b5-1 +13,531 $1.64 $22,204 38,531 D
Ross Thomas M. EVP, GLOBAL SALES 2024-07-09 Sale 10b5-1 −13,531 $4.03 $54,584 25,000 D
Derivatives
Ross Thomas M. EVP, GLOBAL SALES 2024-07-08 Option exercise · Employee Stock Option (right to buy) 10b5-1 −19,802 46,865 D
Ross Thomas M. EVP, GLOBAL SALES 2024-07-09 Option exercise · Employee Stock Option (right to buy) 10b5-1 −13,531 33,334 D
Open-market sales · 33,333 sh · avg $4.03 · $134,366
Loading xslF345X05/form4-07102024_040702.xml…